Search Results - "Pluckrose, Dawn M."

Low-Dose Valganciclovir Prophylaxis Against Cytomegalovirus in Intermediate-Risk Liver and Dual-Abdominal Transplant Recipients by Li, Yihan, Pluckrose, Dawn M., Patolia, Roshani, Arnouk, Serena, Dubrovskaya, Yanina, Papadopoulos, John, Jonchhe, Srijana

“…Background: Low-dose valganciclovir (VGC) for cytomegalovirus (CMV) prophylaxis post-transplant has been employed due to cost and safety. The incidence of CMV…”
Get full text

Hepatitis C viral clearance with coadministration of crushed sofosbuvir/velpatasvir and high-dose pantoprazole after liver transplantation by Pluckrose, Dawn M, Szczepanik, Amanda, Bova, Sarah E, Freedman, Sari R

“…Direct-acting antivirals (DAAs) allow for successful transplantation of livers from hepatitis C nucleic acid test (NAT)-positive donors to negative recipients…”
Get full text

Therapeutic Myths in Solid Organ Transplantation Infectious Diseases by Goodlet, Kellie J, McCreary, Erin K, Nailor, Michael D, Barnes, Darina, Brokhof, Marissa M, Bova, Sarah, Clemens, Evan, Kelly, Beth, Lichvar, Alicia, Pluckrose, Dawn M, Summers, Bryant B, Szempruch, Kristen R, Tchen, Stephanie

“…Abstract Infection management in solid organ transplantation poses unique challenges, with a diverse array of potential pathogens and associated antimicrobial…”
Get full text

Best practices for supporting and improving pharmacy resident research and quality improvement projects by Murphy, John E., Azad, Aniqa, Barreto, Jason N., Coons, Eric M., Coons, James C., Drury, Anna Sahlstrom, Goodlet, Kellie J., Hennessey, Erin K., Jennings, Douglas, Kane‐Gill, Sandra L., Morbitzer, Kathryn, Pluckrose, Dawn M., Sikand, Harminder, Weant, Kyle A.

“…The 2023 ACCP Research Affairs Committee was charged with developing a commentary to address best practices in pharmacy resident research and quality…”
Get full text